Loss of chance associated with sub-optimal HPV vaccination coverage rate in France

by Mathieu Uhart, Marjorie Adam, André Dahlab, Xavier Bresse
Published 2017-06-01

Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy

by Francesco Saverio Mennini, Paolo Bonanni, Florence Bianic, Chiara de Waure, Gianluca Baio, Giacomo Plazzotta, Mathieu Uhart, Alessandro Rinaldi, Nathalie Largeron
Published 2017-07-01

Epidemiological and economic burden of potentially HPV-related cancers in France.

by Laurent Abramowitz, Jean Lacau Saint Guily, Micheline Moyal-Barracco, Christine Bergeron, Hélène Borne, André Dahlab, Xavier Bresse, Mathieu Uhart, Charlotte Cancalon, Laura Catella, Stève Bénard
Published 2018-01-01

Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France.

by Yann de Rycke, Florence Tubach, Alexandre Lafourcade, Sylvie Guillo, Marie Dalichampt, André Dahlab, Xavier Bresse, Mathieu Uhart, Christine Bergeron, Hélène Borne, Charlotte Cancalon, Audrey Lajoinie, Stève Bénard
Published 2020-01-01